Bristol-Myers Squibb Partners with Anthropic to Expand AI Capabilities
Bristol-Myers Squibb (NYSE:BMY) announced a strategic partnership with Anthropic on May 20, 2026, to integrate Claude's advanced reasoning and agentic capabilities into its operations. The collaboration aims to enhance the company’s use of AI beyond conversational tools by embedding it in daily workflows for over 30,000 employees.
Tickers: $BMY
Topics: AI integration clinical development pharma